Intelligence Precision Medicine cannot achieve its promise if entire populations remain underrepresented in the data that fuels it. As multiomic and real-world datasets expand, the next wave of therapeutic innovation will depend on how inclusively we capture and interpret human diversity. This session explores how inclusive health intelligence integrating genomic, transcriptomic, proteomic, and real-world evidence from underrepresented populations can drive discovery across the full translational pipeline. Panelists from leading research institutions, national programs, and data consortia will discuss how diversity in data enhances variant discoveries, strengthens model generalizability, and leads to more representative and effective precision medicine. Together, the panel will outline a vision for inclusive, interoperable, and trustworthy health intelligence that accelerates discovery for all populations.